- Home
- MITK vs BCYC Comparison
MITK vs BCYC Comparison
Compare MITK & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITK
- BCYC
- Stock Information
- Founded
- MITK 1983
- BCYC 2009
- Country
- MITK United States
- BCYC United Kingdom
- Employees
- MITK N/A
- BCYC N/A
- Industry
- MITK Computer peripheral equipment
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- MITK Technology
- BCYC Health Care
- Exchange
- MITK Nasdaq
- BCYC Nasdaq
- Market Cap
- MITK 420.4M
- BCYC 449.5M
- IPO Year
- MITK N/A
- BCYC 2019
- Fundamental
- Price
- MITK $8.67
- BCYC $6.30
- Analyst Decision
- MITK Strong Buy
- BCYC Buy
- Analyst Count
- MITK 2
- BCYC 11
- Target Price
- MITK $13.50
- BCYC $20.73
- AVG Volume (30 Days)
- MITK 279.7K
- BCYC 345.2K
- Earning Date
- MITK 12-15-2025
- BCYC 10-30-2025
- Dividend Yield
- MITK N/A
- BCYC N/A
- EPS Growth
- MITK N/A
- BCYC N/A
- EPS
- MITK 0.33
- BCYC N/A
- Revenue
- MITK $178,134,000.00
- BCYC $28,339,000.00
- Revenue This Year
- MITK $4.11
- BCYC N/A
- Revenue Next Year
- MITK $7.52
- BCYC N/A
- P/E Ratio
- MITK $26.12
- BCYC N/A
- Revenue Growth
- MITK 6.98
- BCYC N/A
- 52 Week Low
- MITK $6.93
- BCYC $6.10
- 52 Week High
- MITK $11.78
- BCYC $21.60
- Technical
- Relative Strength Index (RSI)
- MITK 34.87
- BCYC 36.23
- Support Level
- MITK $8.53
- BCYC $6.17
- Resistance Level
- MITK $9.48
- BCYC $6.89
- Average True Range (ATR)
- MITK 0.25
- BCYC 0.46
- MACD
- MITK -0.05
- BCYC -0.07
- Stochastic Oscillator
- MITK 13.68
- BCYC 7.91
About MITK Mitek Systems Inc.
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.